National Research (NASDAQ:NRC) Shares Down 8.4%

National Research Co. (NASDAQ:NRC)’s stock price dropped 8.4% on Wednesday . The company traded as low as $32.51 and last traded at $32.62. Approximately 13,068 shares traded hands during trading, a decline of 81% from the average daily volume of 68,995 shares. The stock had previously closed at $35.63.

Analyst Ratings Changes

Separately, TheStreet lowered shares of National Research from a “b-” rating to a “c+” rating in a research note on Thursday, January 11th.

National Research Price Performance

The stock has a 50 day moving average price of $37.36 and a two-hundred day moving average price of $39.27. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.67 and a quick ratio of 0.67. The firm has a market capitalization of $709.78 million, a price-to-earnings ratio of 26.90 and a beta of 0.45.

National Research (NASDAQ:NRC) last posted its quarterly earnings results on Tuesday, February 13th. The company reported $0.36 EPS for the quarter. The business had revenue of $38.00 million during the quarter. National Research had a net margin of 20.84% and a return on equity of 47.79%.

National Research Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Friday, March 29th were issued a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a yield of 1.61%. The ex-dividend date of this dividend was Wednesday, March 27th. National Research’s dividend payout ratio (DPR) is presently 38.40%.

Institutional Trading of National Research

Institutional investors have recently bought and sold shares of the business. iA Global Asset Management Inc. purchased a new position in National Research in the third quarter valued at approximately $11,124,000. Comerica Bank purchased a new stake in National Research in the third quarter valued at $6,939,000. Norden Group LLC purchased a new position in shares of National Research during the first quarter worth about $5,170,000. PineStone Asset Management Inc. increased its position in shares of National Research by 128.9% during the fourth quarter. PineStone Asset Management Inc. now owns 153,100 shares of the company’s stock worth $6,057,000 after purchasing an additional 86,202 shares in the last quarter. Finally, Conestoga Capital Advisors LLC lifted its holdings in shares of National Research by 6.0% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 773,215 shares of the company’s stock valued at $34,308,000 after purchasing an additional 43,475 shares during the last quarter. 47.26% of the stock is owned by hedge funds and other institutional investors.

About National Research

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.